Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q1 FY19 results · Apr–Jun 2018
Caplin Point Laboratories reported revenue from operations of ₹125.16 crore and net profit of ₹41.36 crore for Q1 FY19 (Apr–Jun 2018), on a standalone basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 125.16 | — | — | — | — |
| Other income | 18.05 | — | — | — | — |
| Total income | 143.22 | — | — | — | — |
| Profit before tax | 53.14 | — | — | — | — |
| Net profit for the period | 41.36 | — | — | — | — |
| EPS, basic (₹) | 0.00 | — | — | — | — |
| Net margin (%) | 33.0 | — | — |
Standalone
- Filed with BSE
- 07 Aug 2018, 15:05 IST
- Board meeting
- 06 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE